期刊文献+

妊娠期高血压疾病患者凝血和抗凝因子的变化及意义 被引量:5

Change and significance of coagulation factors and anti-coagulation factors in patients with hypertensive disorder complicating pregnancy
原文传递
导出
摘要 目的:探讨妊高征患者凝血和抗凝因子的变化及意义。方法:采用STA-R自动血凝仪分别检测80例妊娠期高血压疾病患者(妊高征组)、25例正常孕妇(对照组)的凝血因子Ⅷ:C、Ⅸ:C、AT(抗凝血酶):C及VWF(血小板表面受体)抗原含量。结果:妊高征组凝血因子Ⅷ:C、Ⅸ:C及VWF:Ag均明显高于对照组(P<0.05或P<0.01);妊高征组AT:C明显低于对照组(P<0.05或P<0.01)。结论:检测凝血因子Ⅷ:C、Ⅸ:C、AT:C及VWF:Ag对诊治妊高征有一定的临床意义。 Objective: To explore the change and significance of coagulation factors and anti -coagulation factors in patients with hypertensive disorder complicating pregnancy (HDCP) . Methods: The contents of coagulation factors VIII: C, IX: C, AT: C, and VWF: Ag of 80 patients with HDCP (HDCP group) and 25 normal pregnant women (control group) were detected by STA -R automatic blood coagulation meter. Results: The contents of coagulation factors Vi : C, IX : C, and VWF : Ag in HDCP group were higher than those in control group ( P 〈 0. 05 or P 〈 0.01 ) ; while the content of AT : C in HDCP group was lower than that in control group ( P 〈 0. 05 or P 〈 0.01 ) . Conclusion: Detecting coagulation factors VII: C, IX: C, AT: C, and VWF: Ag has a certain clinical significance for diagnosis and treatment of HDCP.
出处 《中国妇幼保健》 CAS 北大核心 2012年第34期5482-5483,共2页 Maternal and Child Health Care of China
关键词 妊高征 凝血因子Ⅷ VWF AT Hypertensive disorder complicating pregnancy Coagulation factor VnI VWF AT
  • 相关文献

参考文献4

二级参考文献8

共引文献30

同被引文献50

  • 1Ehrenthal DB, Jurkovitz C, Hoffman M, et al. Prepregnancy body mass index as an independent risk factor for pregnancy-induced hypertension [ J]. Journal of Women's Health ,2011,20( 1 ) :67-72.
  • 2Pabinger I, Grafenhofer H, Kaider A, et al. Preeclampsia and fetal loss in women with history of renous thromboemkolism [ J ]. Alte Rioscler Throbvosc Biol,2001,21 ( 5 ) : 874-879.
  • 3Bartha JL, Gonz61ez-Bugatto F, Fern6ndez-Mactas R, et al. Metabolic syndrome in normal and complicated pregnancies [ J ]. Eur J Obstet Gyneco! Reprod Biol,2008,137(2) :178-184.
  • 4Morikawa M, Yamada T, Yamada T. Pregnancy-induced antithrombin deficiency [J]. Perinat Med,2010,38(4) :379-385.
  • 5Sucak GT, Acar K, Sucak A, et al. Increased global fibrinolytie capac- ity as a clue for activated fibfinolysis in pre-eclampsia[ J:. Blood Co- agul Fibrinolysis ,2006,17 ( 5 ) :347-352.
  • 6Maynard SE,Karumanchi SA.Angiogenic factors and preeclampsia[J].Semin Nephrol,2011,31(1):33-46.
  • 7Driul L,Damante G,D Elia A,et al.Genetic thrombophilias and uterine artery Doppler velocimetry and preeclampsia[J].Int J Gynaecol Obstet,2005,88(3):265-270.
  • 8Osmanagaoglu MA,Topcuoglu K,Ozeren M,et al.Coagulation inhibitors in preeclamptic pregnant women[J].Arch Gynecol Obstet,2005,271(3):227-230.
  • 9Saisto T,Tiitinen A,Ulander VM,et al.Clinical cure of severe early onset preeclampsia with low molecular weight heparin therapy in primigravida with hyperreactio luteinalis and thrombophilia[J].Hum Reprod,2004,19(3):725-728.
  • 10Sucak GT,Acar K,Sucak A,et al.Increased global fibrinolytic capacity as a clue for activated fibrinolysis in pre-eclampsia[J].Blood Coagul Fibrinolysis,2006,17(5):347-352.

引证文献5

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部